Log in

6887 Sunshine Lake Pharma Co., Ltd. HKEX · China

Sunshine Lake Pharma Co. (6887) news

Sunshine Lake Pharma Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6887, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Sunshine Lake Pharma Co. news

We have not published a story on Sunshine Lake Pharma Co. yet. When there is news, it will appear here.

Questions about Sunshine Lake Pharma Co.

What is the ticker symbol of Sunshine Lake Pharma Co.?

Sunshine Lake Pharma Co., Ltd. trades under the ticker 6887 on HKEX.

Where is Sunshine Lake Pharma Co. listed?

Sunshine Lake Pharma Co., Ltd. is listed on HKEX.

Which country or territory is Sunshine Lake Pharma Co. listed under?

Our directory records Sunshine Lake Pharma Co., Ltd. under China.

What does Sunshine Lake Pharma Co. do?

Our directory classifies Sunshine Lake Pharma Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Sunshine Lake Pharma Co.?

The ISIN recorded for Sunshine Lake Pharma Co., Ltd. is CNE1000070M8.

Does aibio.space cover Sunshine Lake Pharma Co.?

aibio.space lists Sunshine Lake Pharma Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Sunshine Lake Pharma Co.?

Companies in our directory listed in the same country and business area as Sunshine Lake Pharma Co.: TransThera Sciences (Nanjing)., Jiangsu Cowin Biotech Co., Ascletis Pharma, Edding Genor Group Holdings, PegBio Co., Laekna.

Investor discussion: Sunshine Lake Pharma Co.

Members talk about Sunshine Lake Pharma Co. (6887). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Sunshine Lake Pharma Co., newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: (1) PROPOSED GRANT OF REPURCHASE MANDATE; (2) PROPOSED EXTENSION OF GENERAL ISSUE MANDATE; (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (4) NOTICE OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING. Source

  2. Financings

    Share or debt issue: PROPOSED GRANT OF GENERAL ISSUE MANDATE AND NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING. Source

  3. Listings

    Trading status: JOINT ANNOUNCEMENT UPDATE REGARDING CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. (1) SATISFACTION OF CONDITIONS TO IMPLEMENTATION AND IMPLEMENTATION OF THE MERGER (2) APPOINTMENT OF AGENT FOR ODD LOT ARRANGEMENT. Source

  4. Listings

    Trading status: JOINT ANNOUNCEMENT WITHDRAWAL OF LISTING OF H SHARES AND EXPECTED TIMELINE FOR THE WITHDRAWAL OF LISTING AND THE IMPLEMENTATION OF THE SHARE EXCHANGE. Source

  5. Mergers

    Transaction under the Listing Rules: JOINT ANNOUNCEMENT IN RESPECT OF THE SPECIAL DIVIDEND. Source

  6. Listings

    Trading status: JOINT ANNOUNCEMENT RESULTS OF EXERCISE OF RIGHT OF DISSENTING SHAREHOLDERS. Source

  7. Listings

    Trading status: JOINT ANNOUNCEMENT (1) POLL RESULTS OF THE EGM AND THE H SHAREHOLDERS' CLASS MEETING HELD ON MONDAY, 21 JULY 2025 RELATING TO THE PROPOSED CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. (2) PROPOSED WITHDRAWAL OF LISTING AND LAST DAY OF TRADING (3) PROPOSED SPECIAL DIVIDEND AND (4) INFORMATION REGARDING EXERCISE OF RIGHT OF DISSENTING SHAREHOLDERS. Source

  8. Listings

    Trading status: COMPOSITE DOCUMENT (1) PROPOSED CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. (2) PROPOSED SPECIAL DIVIDEND (3) PROPOSED WITHDRAWAL OF LISTING (4) NOTICE OF EXTRAORDINARY GENERAL MEETING AND (5) NOTICE OF THE H SHAREHOLDERS' CLASS MEETING. Source

  9. Listings

    Trading status: JOINT ANNOUNCEMENT (1) PROPOSED CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. (2) PROPOSED WITHDRAWAL OF LISTING AND (3) DESPATCH OF COMPOSITE DOCUMENT. Source

Press releases

Headlines of Sunshine Lake Pharma Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    VOLUNTARY ANNOUNCEMENT INSULIN DEGLUDEC AND INSULIN ASPART INJECTION OBTAINED MARKETING APPROVAL FROM THE CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION

  2. HKEXnews

    INSIDE INFORMATION FILING WITH THE CSRC IN RELATION TO THE PROPOSED IMPLEMENTATION OF H SHARE FULL CIRCULATION

  3. HKEXnews

    SUPPLEMENTAL ANNOUNCEMENT WITH RESPECT TO CONNECTED TRANSACTIONS

  4. HKEXnews

    CHANGE OF COMPLIANCE ADVISER

  5. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026

  6. HKEXnews

    PROFIT WARNING

  7. HKEXnews

    VOLUNTARY ANNOUNCEMENT FIRST COMMERCIAL SHIPMENT OF INSULIN GLARGINE INJECTION TO THE UNITED STATES

  8. HKEXnews

    VOLUNTARY ANNOUNCEMENT IN RELATION TO THE MARKETING APPROVAL OF INSULIN DEGLUDEC INJECTION BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA)

  9. HKEXnews

    VOLUNTARY ANNOUNCEMENT UPDATE ON PROPOSED INCREASE IN SHAREHOLDING IN THE COMPANY BY THE CONTROLLING SHAREHOLDER AND DIRECTOR

  10. HKEXnews

    VOLUNTARY ANNOUNCEMENT (1) PROPOSED INCREASE IN SHAREHOLDING IN THE COMPANY BY THE CONTROLLING SHAREHOLDER AND DIRECTOR; AND (2) ON-MARKET SHARE REPURCHASE

  11. HKEXnews

    VOLUNTARY ANNOUNCEMENT (1) UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS; AND (2) BUSINESS UPDATE

  12. HKEXnews

    CONNECTED TRANSACTION (1) ESTABLISHMENT OF LIMITED PARTNERSHIP FUND; AND (2) ACQUISITION OF LAND USE RIGHTS

  13. HKEXnews

    ELECTION OF CHAIRMAN OF THE BOARD; APPOINTMENT OF MEMBERS OF EACH OF THE BOARD COMMITTEES; AND ENGAGEMENT OF SENIOR MANAGEMENT OF THE COMPANY

  14. HKEXnews

    ARTICLES OF ASSOCIATION

  15. HKEXnews

    POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING AND ELECTION OF EMPLOYEE DIRECTOR TO THE SECOND SESSION OF THE BOARD

  16. HKEXnews

    VOLUNTARY ANNOUNCEMENT CLINICAL TRIAL APPLICATION FOR NOVEL LY6G6D/4-1BB-TARGETING BISPECIFIC ANTIBODY HEC-921 INJECTION ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF THE PRC

  17. HKEXnews

    CHANGE OF AUTHORISED REPRESENTATIVE AND CHANGE OF BOOK CLOSURE PERIOD AND RECORD DATE

  18. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  19. HKEXnews

    PROPOSED RE-ELECTION AND APPOINTMENTS OF DIRECTORS OF THE SECOND SESSION OF THE BOARD

  20. HKEXnews

    PROPOSED ABOLISHMENT OF THE BOARD OF SUPERVISORS, PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND PROPOSED AMENDMENTS TO CERTAIN GOVERNANCE RULES

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:6887 on TradingView.

Listing details

Sunshine Lake Pharma Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6887, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Sunshine Lake Pharma Co., Ltd.
Ticker
6887
Listing
HKEX
Country or territory
China
Business scope
Biotechnology
ISIN
CNE1000070M8
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.